Advanced search
Publication Cover
International Medical Case Reports Journal Volume 15, 2022 - Issue
Submit an article Journal homepage
308
Views
23
CrossRef citations to date
0
Altmetric
Case Report

Combined Central Retinal Artery and Vein Occlusion with Ischemic Optic Neuropathy After COVID-19 Vaccination

Sol Lee1 Department of Clinical Research, Retina Macula Institute, Torrance, CA, USAView further author information
,
Kamalesh K Sankhala2 Cedars-Sinai Medical Center, Beverly Hills, CA, USAView further author information
,
Swaraj Bose3 NeuroOphthalmology & Orbital Surgery, Cedars-Sinai Medical Towers, NeuroEyeOrbit Institute, Los Angeles, CA, USAView further author information
&
Ron P Gallemore1 Department of Clinical Research, Retina Macula Institute, Torrance, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6116-6026View further author information
ORCID Icon
Pages 7-14 | Published online: 16 Jan 2022

References

  • Center for Disease Control and Prevention. Different COVID-19 vaccines. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html. Accessed May 24, 2021.
  • ASHP, ISMP, USP. FAQ for optimizing COVID-19 vaccine preparation and safety. Available from: https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/FAQ-optimizing-covid-vaccine-prep-safety.ashx. Accessed May 24, 2021.
  • Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577
  • Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389
  • Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021;384(22):2092–2101. doi:10.1056/NEJMoa2104840
  • Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021;384(22):2124–2130. doi:10.1056/NEJMoa2104882
  • Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med. 2021;384(20):1964–1965. doi:10.1056/NEJMc2105869
  • Brown DM, Heier JS, Clark WL, et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the Phase 3 COPERNICUS study. Am J Ophthalmol. 2013;155(3):429–437.e7. doi:10.1016/j.ajo.2012.09.026
  • Boyer D, Heier J, Brown DM, et al. Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS study. Ophthalmology. 2012;119(5):1024–1032. doi:10.1016/j.ophtha.2012.01.042
  • Korobelnik JF, Holz FG, Roider J, et al. Intravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology. 2014;121(1):202–208. doi:10.1016/j.ophtha.2013.08.012
  • Holz FG, Roider J, Ogura Y, et al. VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the Phase III GALILEO study. Br J Ophthalmol. 2013;97(3):278–284. doi:10.1136/bjophthalmol-2012-301504
  • Asahi MG, Bobarnac Dogaru GL, Onishi SM, Gallemore RP. Strong topical steroid, NSAID, and carbonic anhydrase inhibitor cocktail for treatment of cystoid macular edema. Int Med Case Rep J. 2015;8:305–312. doi:10.2147/IMCRJ.S92794
  • Mareev VY, Orlova YA, Pavlikova EP, et al. Steroid pulse -therapy in patients With coronAvirus Pneumonia (COVID-19), sYstemic inFlammation And Risk of vEnous thRombosis and thromboembolism (WAYFARER Study). Kardiologiia. 2020;60(6):15–29. English, Russian. doi:10.18087/cardio.2020.6.n1226
  • Nutescu EA, Burnett A, Fanikos J, Spinler S, Wittkowsky A. Pharmacology of anticoagulants used in the treatment of venous thromboembolism [published correction appears in J Thromb Thrombolysis. 2016 Aug;42(2):296–311]. J Thromb Thrombolysis. 2016;41(1):15–31. doi:10.1007/s11239-015-1314-3
  • Oldenburg J, Klamroth R, Langer F, et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hamostaseologie. 2021. doi:10.1055/a-1469-7481
  • Khan P, Khan L, Awasthi U, Khan A, Siddique Z, Chand R. Pentoxifylline: a therapeutic remedy for optic neuropathies. J Evol Med Dent Sci. 2013;2:3516–3522. doi:10.14260/jemds/722
  • Hurst KV, O’Callaghan JM, Handa A. Quick reference guide to apixaban [published correction appears in Vasc Health Risk Manag. 2017 Oct 26;13:413]. Vasc Health Risk Manag. 2017;13:263–267. doi:10.2147/VHRM.S121944
  • Hayreh SS. Management of ischemic optic neuropathies. Indian J Ophthalmol. 2011;59(2):123–136. doi:10.4103/0301-4738.77024
  • Miller NR. Current concepts in the diagnosis, pathogenesis, and management of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2011;31(2):e1–3. doi:10.1097/WNO.0b013e31821f955c
  • Atkins EJ, Bruce BB, Newman NJ, Biousse V. Treatment of nonarteritic anterior ischemic optic neuropathy. Surv Ophthalmol. 2010;55(1):47–63. doi:10.1016/j.survophthal.2009.06.008
  • Quiros P, Hirsch L, Sadun A. The use of pentoxifylline in the prevention of second eye involvement in patients with NAION. North Am Neuro Ophthalmol Soc. 2011;poster 120. https://collections.lib.utah.edu/details?id=181718&page=17&facet_setname_s=ehsl_novel_nam

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.